On March 27, 1827, the day after Ludwig van Beethoven's death, his associates uncovered a hidden trove of documents in his desk. Among them was the Heiligenstadt Testament, a letter written in 1802 to ...

Four development candidates in clinical studies with data anticipated this year, continuing rapid progress of antiviral pipeline –– Interim ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

One stormy Monday in March, 1827, the German composer Ludwig van Beethoven passed away after a protracted illness.

Hepatitis B virus infection remains one of the leading causes of liver disease, including cirrhosis and hepatocellular carcinoma.

The US joins Moldova, Hong Kong, and New Zealand as countries to greenlight the company's Phase I trial of PBGENE-HBV.

Precision BioSciences (DTIL) announced that the U.S. Food and Drug Administration or FDA has cleared the Investigational New Drug application ...

Chronic hepatitis B virus (HBV) infection continues to pose a major global health threat. The virus evades immune responses and antiviral therapies due to the persistence of covalently closed circular ...

Hepatitis B and C still survive in the dark, driven by a lack of information, unhygienic medical procedures, and poor access ...